Background: Bicalutamide monotherapy is a valuable option for prostate cancer (PCa) patients who wish to avoid the consequences of androgen deprivation; however, this treatment induces gynaecomastia and mastalgia in most patients. Tamoxifen is safe and effective in preventing breast events induced by bicalutamide monotherapy without affecting...
-
2010 (v1)PublicationUploaded on: April 14, 2023
-
2018 (v1)Publication
The multidisciplinary management of oncologic patients is identified as the bottom line element of quality in tumor care.
Uploaded on: April 14, 2023 -
2021 (v1)Publication
BACKGROUND: Prostate cancer (PCa) is the second most common neoplasm in male patients. To date, there's no certain indication about the maximum waiting time (WT) acceptable for treatment beginning and the impact on oncological and functional outcomes has not been well established.METHODS: Data from the National Research Council PCa monitoring...
Uploaded on: April 14, 2023 -
2020 (v1)Publication
Purpose Therapeutic strategies for prostate cancer (PCa) have been evolving dramatically worldwide. The current article reports on the evolution of surgical management strategies for PCa in Italy. Methods The data from two independent Italian multicenter projects, the MIRROR-SIU/LUNA (started in 2007, holding data of 890 patients) and the...
Uploaded on: April 14, 2023 -
2022 (v1)Publication
We aimed to overcome intratumoral heterogeneity in clear cell renal cell carcinoma (clear-RCC). One hundred cases of clearRCC were sampled. First, usual standard sampling was applied (1 block/cm of tumor); second, the whole tumor was sampled, and 0.6 mm cores were taken from each block to construct a tissue microarray; third, the residual...
Uploaded on: April 14, 2023